Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining the Intestinal eCBome and Oxylipin Signaling Systems in a TDP-43 Mouse Model of Frontotemporal Dementia.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Assessment of the therapeutic effect of IGS2.7, a CK1δ protein kinase inhibitor, in combination with riluzole for the treatment of ALS-associated TDP-43 proteinopathy.

Neuropharmacology·2025
Same author

Relevance of a peripheral site of action outside the brain-blood barrier for the beneficial effects of CB<sub>2</sub> receptor activation in experimental ALS in male mice.

Cell communication and signaling : CCS·2025
Same author

Ageing, Neurodegeneration and the Endocannabinoid System.

Current topics in behavioral neurosciences·2025
Same author

Preclinical evaluation of cannabidiolic acid as a neuroprotective agent in TDP-43 transgenic mice, an experimental model of amyotrophic lateral sclerosis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

Neurodegenerative Diseases: Pathogenesis and Preclinical Models for Translational Drug Discovery.

Toxicologic pathology·2025

Related Experiment Video

Updated: May 27, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Cannabinoids, multiple sclerosis and neuroprotection.

Eva de Lago1, María Gómez-Ruiz, Miguel Moreno-Martet

  • 1Departamento de Bioquímica y Biología Molecular and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Facultad de Medicina, Universidad Complutense, 28040 Madrid, Spain. elagofem@med.ucm.es.

Expert Review of Clinical Pharmacology
|November 25, 2011
PubMed
Summary

Cannabinoids show neuroprotective potential in multiple sclerosis (MS) by acting as antioxidants and anti-inflammatories. This review explores their role in protecting the central nervous system (CNS) beyond symptom management.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Related Experiment Videos

Last Updated: May 27, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

Area of Science:

  • Neuroscience
  • Immunology
  • Pharmacology

Background:

  • The cannabinoid signaling system is crucial for central nervous system (CNS) homeostasis.
  • Alterations in this system are implicated in neurodegenerative diseases like multiple sclerosis (MS).
  • MS involves inflammation, demyelination, and axonal damage, with axonal loss contributing to disability.

Purpose of the Study:

  • To review the neuroprotective potential of cannabinoids in MS.
  • To explore mechanisms beyond symptom alleviation and anti-inflammatory effects.
  • To highlight antioxidant, anti-inflammatory, and anti-excitotoxic properties.

Main Methods:

  • Review of existing scientific literature on cannabinoids and MS.
  • Analysis of studies focusing on neuroprotection.
  • Examination of cannabinoid receptor (CB1, CB2) mediated and other mechanisms.

Main Results:

  • Cannabinoids demonstrate significant neuroprotective actions in MS.
  • These effects are attributed to antioxidant, anti-inflammatory, and anti-excitotoxic properties.
  • Cannabinoids may offer therapeutic benefits by protecting neurons and axons.

Conclusions:

  • Cannabinoids represent a promising therapeutic avenue for MS, targeting neuroprotection.
  • Further research into cannabinoid mechanisms could lead to novel MS treatments.
  • The neuroprotective potential of cannabinoids warrants clinical investigation for MS management.